These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
227 related articles for article (PubMed ID: 28230020)
21. [Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors]. Zhao M; Wang JP; Li W; Huang ZL; Zhang FJ; Fan WJ; Zhang L; Li XS; Pan CC; Wu PH Zhonghua Yi Xue Za Zhi; 2011 May; 91(17):1167-72. PubMed ID: 21756768 [TBL] [Abstract][Full Text] [Related]
22. [High intensity focused ultrasound therapy combined with transcatheter arterial chemoembolization for advanced hepatocellular carcinoma]. Jin CB; Wu F; Wang ZB; Chen WZ; Zhu H Zhonghua Zhong Liu Za Zhi; 2003 Jul; 25(4):401-3. PubMed ID: 12921577 [TBL] [Abstract][Full Text] [Related]
23. Transcatheter arterial chemoembolization combined with simultaneous DynaCT-guided microwave ablation in the treatment of small hepatocellular carcinoma. Li Z; Jiao D; Han X; Si G; Li Y; Liu J; Xu Y; Zheng B; Zhang X Cancer Imaging; 2020 Jan; 20(1):13. PubMed ID: 32000862 [TBL] [Abstract][Full Text] [Related]
24. Analysis of therapeutic effectiveness and prognostic factor on argon-helium cryoablation combined with transcatheter arterial chemoembolization for the treatment of advanced hepatocellular carcinoma. Huang C; Zhuang W; Feng H; Guo H; Tang Y; Chen H; Huang Y J Cancer Res Ther; 2016 Dec; 12(Supplement):C148-C152. PubMed ID: 28230008 [TBL] [Abstract][Full Text] [Related]
25. [Transcatheter arterial chemoembolization plus percutaneous thermal ablation in large hepatocellular carcinoma: clinical observation of efficacy and predictors of prognostic factors]. Fan WZ; Yang JY; Lü MD; Xie XY; Yin XY; Huang YH; Kuang M; Li HP; Xu HX; Li JP Zhonghua Yi Xue Za Zhi; 2011 Aug; 91(31):2190-4. PubMed ID: 22094036 [TBL] [Abstract][Full Text] [Related]
26. Individualized treatment models based on blood supply characteristics in hepatocellular carcinoma using color Doppler hemodynamics. Si Q; Mu H; Yan G; Qian X; Xu C; Wang X; Tong W Hepatogastroenterology; 2007 Mar; 54(74):334-41. PubMed ID: 17523269 [TBL] [Abstract][Full Text] [Related]
27. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center. Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222 [TBL] [Abstract][Full Text] [Related]
28. Balloon-Occluded MWA (b-MWA) Followed by Balloon-Occluded TACE (b-TACE): Technical Note on a New Combined Single-Step Therapy for Single Large HCC. Iezzi R; Posa A; Tanzilli A; Carchesio F; Pompili M; Manfredi R Cardiovasc Intervent Radiol; 2020 Nov; 43(11):1702-1707. PubMed ID: 32676963 [TBL] [Abstract][Full Text] [Related]
29. [Clinical outcomes of radiofrequency ablation combined with transcatheter arterial chemoembolization for the treatment of hepatocellular carcinoma: a single-center experience]. Lin JJ; Wu W; Jiang XF; Jin XJ; Lu LJ; Bao LW Zhonghua Zhong Liu Za Zhi; 2013 Feb; 35(2):144-7. PubMed ID: 23714672 [TBL] [Abstract][Full Text] [Related]
30. Large primary hepatocellular carcinoma: transarterial chemoembolization monotherapy versus combined transarterial chemoembolization-percutaneous microwave coagulation therapy. Xu LF; Sun HL; Chen YT; Ni JY; Chen D; Luo JH; Zhou JX; Hu RM; Tan QY J Gastroenterol Hepatol; 2013 Mar; 28(3):456-63. PubMed ID: 23216261 [TBL] [Abstract][Full Text] [Related]
31. Cytokine-induced killer cells in combination with transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma patients. Huang ZM; Li W; Li S; Gao F; Zhou QM; Wu FM; He N; Pan CC; Xia JC; Wu PH; Zhao M J Immunother; 2013 Jun; 36(5):287-93. PubMed ID: 23719239 [TBL] [Abstract][Full Text] [Related]
32. Transcatheter arterial chemoembolization (TACE) for lymph node metastases in patients with hepatocellular carcinoma. Wu H; Liu S; Zheng J; Ji G; Han J; Xie Y J Surg Oncol; 2015 Sep; 112(4):372-6. PubMed ID: 26368066 [TBL] [Abstract][Full Text] [Related]
33. Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial. Peng ZW; Zhang YJ; Liang HH; Lin XJ; Guo RP; Chen MS Radiology; 2012 Feb; 262(2):689-700. PubMed ID: 22157201 [TBL] [Abstract][Full Text] [Related]
35. Radiation Segmentectomy versus TACE Combined with Microwave Ablation for Unresectable Solitary Hepatocellular Carcinoma Up to 3 cm: A Propensity Score Matching Study. Biederman DM; Titano JJ; Bishay VL; Durrani RJ; Dayan E; Tabori N; Patel RS; Nowakowski FS; Fischman AM; Kim E Radiology; 2017 Jun; 283(3):895-905. PubMed ID: 27930089 [TBL] [Abstract][Full Text] [Related]
36. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma. Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905 [TBL] [Abstract][Full Text] [Related]
37. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma. Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205 [TBL] [Abstract][Full Text] [Related]
38. [Therapeutic effects of sorafenib combined with transcatheter arterial chemoembolization and microwave ablation on postsurgical recurrent hepatocellular carcinoma]. Hua XD; He ZY Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):790-2. PubMed ID: 23291076 [TBL] [Abstract][Full Text] [Related]
39. Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial. Peng ZW; Zhang YJ; Chen MS; Xu L; Liang HH; Lin XJ; Guo RP; Zhang YQ; Lau WY J Clin Oncol; 2013 Feb; 31(4):426-32. PubMed ID: 23269991 [TBL] [Abstract][Full Text] [Related]
40. Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization. Morimoto M; Numata K; Kondou M; Nozaki A; Morita S; Tanaka K Cancer; 2010 Dec; 116(23):5452-60. PubMed ID: 20672352 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]